Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 61,274	$ 74,603
Marketable securities, current	174,397	173,934
Accounts receivable	2,883	2,401
Prepaid expenses and other current assets	6,817	7,172
Total current assets	245,371	258,110
Marketable securities, non-current	32,600	48,563
Property and equipment, net	4,492	4,744
Right-of-use asset	39,090	40,532
Restricted cash	3,443	3,443
Other assets	3,865	3,683
Total assets	328,861	359,075
Current liabilities:
Accounts payable	773	858
Accrued expenses and other current liabilities	9,830	13,314
Deferred revenue, current	10,124	12,493
Operating lease liability, current	6,522	6,367
Total current liabilities	27,249	33,032
Deferred revenue, net of current	15,440	15,841
Operating lease liability, net of current	51,925	53,615
Total liabilities	94,614	102,488
Commitments and contingencies (see Note 12)
Stockholders’ equity:
Preferred stock, par value of $0.0001 per share; 10,000,000 shares authorized, and no shares issued or outstanding as of March 31, 2026 and December 31, 2025, respectively	0	0
Common stock, par value of $0.0001 per share; 300,000,000 shares authorized as of March 31, 2026, and December 31, 2025, respectively, and 104,036,350 and 96,914,418 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	10	9
Additional paid-in capital	998,381	995,221
Accumulated other comprehensive income	(322)	50
Accumulated deficit	(763,822)	(738,693)
Total stockholders’ equity	234,247	256,587
Total liabilities and stockholders’ equity	$ 328,861	$ 359,075
Common stock, shares authorized (in shares)	300,000,000	300,000,000